5 Best Logistics Stocks To Own For 2014

LONDON -- A month can be a long time when looking at the share price of a particular stock. Here are two companies that have come out of the last 30 days at opposite ends of the profit/loss spectrum:

1. Ocado
The share price of�Ocado� (LSE: OCDO  ) has advanced nearly 54% during the last four weeks or so. The gain is due entirely to news that the firm will now partner with�William Morrison Supermarkets�to help the supermarket move into the online delivery market.

The 25-year agreement will allow Morrisons to license certain technology, logistics, and distribution services in order for the chain to start to build its own online shopping service. In addition, Ocado has agreed to sell to Morrisons half the capacity of its fulfilment center at Dordon.

Ocado has received an up-front payment of 165 million pounds for the deal, most of which will be put back into the research and development of new technology. The payment was a welcome boost to Ocado's balance sheet, and will go some way to reduce the group's financial costs.

Best Canadian Stocks To Invest In 2015: Titan Pharmaceuticals Inc (TTNP.OB)

Titan Pharmaceuticals, Inc., incorporated in February 1992, is a biopharmaceutical company developing therapeutics primarily for the treatment of central nervous system (CNS) disorders. The Company is focused primarily on clinical development of products that include Probuphine for the treatment of opioid addiction; Iloperidone: for the treatment of schizophrenia and related psychotic disorders, and Spheramine for the treatment of advanced Parkinson�� disease. Titan Pharmaceuticals is directly developing its product candidates and also utilizing corporate partnerships, including a collaboration with Bayer Schering Pharma AG, Germany (Bayer Schering) for the development of Spheramine to treat Parkinson�� disease, and Vanda Pharmaceuticals, Inc. (Vanda) for the development of iloperidone for the treatment of schizophrenia and related psychotic disorders.

Probuphine

Probuphine is the first product to utilize the Company�� ProNeura long-ter m drug delivery technology. Probuphine is designed to provide continuous, long-term therapeutic levels of the drug buprenorphine, an approved agent for the treatment of opioid addiction. In December 2007, the Company completed enrollment in a randomized, double-blind, placebo-controlled, multi-center Phase III clinical study of Probuphine in the treatment of opioid addiction. This 150 patient study, which is being conducted in the United States, will evaluate the safety and effectiveness of treatment with Probuphine versus placebo in reducing opioid addiction over 24 weeks of treatment. This study is part of a registration directed program intended to obtain marketing approval of Probuphine for the treatment of opioid addiction in Europe and the United States.

Iloperidone

Iloperidone was evaluated in a Phase III program comprising over 3,500 patients at more than 200 sites in 24 countries, administered and funded by Novartis Pharma AG (Novartis). In three completed efficacy studies conducted by Novartis, ! i! loperidone statistically reduced the symptoms of schizophrenia compared to placebo. Iloperidone has also been investigated in three 12-month safety studies, which confirm safety and tolerability. A dose dependent increase in the Q-T Corrected (QTc) interval was observed and investigated further in a clinical study, and no clinically significant adverse events were observed. In September 2007, Vanda submitted a new drug application (NDA) with the United States Food and Drug Administration (FDA) for iloperidone. The NDA for iloperidone was officially accepted for review by the FDA in November 2007.

Spheramine

Spheramine is a cell-based therapeutic that utilizes the Company�� cell-coated microcarrier (CCM) technology, which enables the development of cell-based therapies for minimally invasive, site-specific delivery to the central nervous system of therapeutic factors precisely where they are needed. Spheramine consists of microcarriers coated wit h human retinal pigment epithelial cells that are intended to enhance brain levels of dopamine, a neurotransmitter deficient in certain brain regions in Parkinson�� disease, leading to movement disorders. Preclinical studies have demonstrated the preliminary efficacy and safety of Spheramine, including blinded studies in a primate model of Parkinson�� disease. In June 2007, enrollment was completed in a current multi-center, randomized, double-blind, placebo-controlled clinical trial of Spheramine in Parkinson�� disease. This Phase IIb clinical study enrolled 71 patients with advanced Parkinson�� disease (Hoehn and Yahr Stages III and IV) to further evaluate the efficacy, safety, and tolerability of Spheramine.

Bayer Schering, the Company�� corporate partner for worldwide development and commercialization of Spheramine, is funding the clinical development program for Spheramine. Under an agreement, Bayer Schering has received exclusive, worldwide deve lopment, manufacturing and commercialization rights, an! d, in! ad! dition! to the clinical and manufacturing development funding and milestone payments, Bayer Schering will pay Titan Pharmaceuticals a royalty on future product sales.

Advisors' Opinion:

• [By C.R. Jackson]

  Fanapt was discovered by Hoechst Marion Roussel in 1995 as a novel atypical antipsychotic agent. Hoechst was a German life-sciences company that became Aventis Deutschland after its merger with France's Rhône-Poulenc in 1999. When the company joined with Sanofi-Synthélabo in 2004, it became a subsidiary of the Sanofi-Aventis (SNY) the French pharmaceutical conglomerate. In 1997, Hoechst sold the research rights to Titan Pharmaceuticals (TTNP.OB). Then Titan quickly sold the worldwide rights to Novartis in 1998. Novartis then sold the Phase 3 development rights for loperidone to Vanda in 2004. Vanda originally attempted to get FDA approval for Fanapt in 2008, but the FDA refused to approve iloperidone. The agency required an additional clinical trial.

5 Best Logistics Stocks To Own For 2014: Ryanair (RYAAY)

Ryanair Holdings plc (Ryanair Holdings), incorporated in 1996, is a holding company for Ryanair Limited (Ryanair). Ryanair operates a low-cost, scheduled-passenger airline serving short-haul, point-to-point routes between Ireland, the United Kingdom, Continental Europe, and Morocco. As of June 30, 2012, the Company offered approximately over 1,500 scheduled short-haul flights per day serving approximately 160 airports largely throughout Europe with an operating fleet of 294 aircraft flying approximately 1,500 routes. Ryanair sells seats on a one-way basis. The Company also holds a 29.8% interest in Aer Lingus Group plc. As of June 30, 2012, Ryanair�� operating fleet was composed of 294 Boeing 737-800 aircraft, each having 189 seats. Ryanair�� fleet totaled 294 Boeing 737-800s at March 31, 2012. As of June 30, 2012, Ryanair owned and operated four Boeing 737-800 full flight simulators for pilot training. Ryanair provides ancillary services and engages in other activities connected with its core air passenger service, including non-flight scheduled services, Internet-related services, and the in-flight sale of beverages, food, and merchandise. As part of its non-flight scheduled and Internet-related services Ryanair incentivizes ground service providers at airports it serves to levy correct excess baggage charges for any baggage, which exceeds Ryanair�� published baggage allowances. Excess baggage charges are recorded as non-flight scheduled revenue. Ryanair distributes accommodation services and travel insurance through its Website. For hotel services, Ryanair has a contract with Hotelscombined PTY Ltd. (Hotelscombined), which operates a price comparison Website, pursuant to which Hotelscombined handles all aspects of such services marketed through Ryanair�� Website and pays a fee to Ryanair. Ryanair also has contracts with other accommodation providers that enable Ryanair to offer hostel, bed-and-breakfast, guesthouse, villa and apartment accommodation to its customers. In addition Ryanair has a contract with Hertz, pursuant to which Hertz handles all car rental services marketed through Ryanair�� Website or telephone reservation system. Ryanair also sells bus and rail tickets onboard its aircraft and through its Website. Ryanair also sells attractions and activities on its Website. Ryanair sells gift vouchers on its Website, which are also redeemable online. The Company has an contract with Webloyalty International Ltd, which offers Ryanair�� customers who have a United Kingdom, German or French billing address a retail discount and cash-back program. Ryanair has agreements, pursuant to which the Company promotes Ryanair-branded credit cards issued by MBNA, GE Money, Access Prepaid and Banco Santander on its Internet site. The MBNA agreement relates to Irish residents only, the GE Money agreement relates to Swedish and Polish residents only and the Banco Santander agreement relates to United Kingdom residents only. During the fiscal year ended March 31, 2012, Ryanair rolled out handheld Electronic Point of Sale (EPOS) devices across its route network. These EPOS devices replaced manual and paper based systems on board the aircraft. The EPOS device enables cabin crew to sell and record their on-board sales transactions. The EPOS device also issues bus and rail tickets and tickets for tourist attractions. The Company also offers reserved seating in twenty-one extra legroom seats on each aircraft for a fee on certain routes. Ryanair provides its own aircraft and passenger handling and ticketing services at Dublin Airport. Third parties provide these services to Ryanair at other airports it serves. Servisair plc provides Ryanair�� ticketing, passenger and aircraft handling, and ground handling services at airports in Ireland and the United Kingdom(excluding London (Stansted) Airport where these services are provided by Swissport Ltd.), while similar services in continental Europe are provided by the local airport authorities, either directly or through sub-contractors. Advisors' Opinion:

• [By Monica Gerson]

  Ryanair Holdings plc (NASDAQ: RYAAY) dipped 4.09% to $49.43 in pre-market trading after falling 1.06% on Thursday.

  Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

• [By Jake L'Ecuyer]

  Equities Trading UP
  Ryanair Holdings plc (NASDAQ: RYAAY) shares shot up 6.55 percent to $54.32 after the company reported full-year results. Ryanair's net profit for the year ended March 31 slipped to 522.8 million euros ($716 million), versus a year-ago profit of EUR569.3 million.

• [By Luke Jacobi]

  Ryanair Holdings plc (NASDAQ: RYAAY) shares were up nearly 6.97 percent into the close to $54.53 after the company reported full-year results. Ryanair's net profit for the year ended March 31 slipped to 522.8 million euros ($716 million), versus a year-ago profit of 569.3 million euros.

5 Best Logistics Stocks To Own For 2014: Speedway Motorsports Inc.(TRK)

Speedway Motorsports, Inc., through its subsidiaries, operates as a promoter, marketer, and sponsor of motor sports activities in the United States. The company principally owns and operates Atlanta Motor Speedway, Bristol Motor Speedway, Charlotte Motor Speedway, Infineon Raceway, Kentucky Speedway, Las Vegas Motor Speedway, New Hampshire Motor Speedway, and Texas Motor Speedway racing facilities. The company also provides souvenir merchandising services; food, beverage, and hospitality catering services; and radio programming, production, and distribution services. In addition, it develops electronic media promotional programming; and distributes wholesale and retail racing, and other sports related souvenir merchandise and apparel. Further, the company manufactures and distributes smaller-scale, modified racing cars and parts; and produces and sells an environmentally-friendly micro-lubricant. Speedway Motorsports has a joint venture with International Speedway Corporat ion to produce, market, and sell licensed motorsports collectible and consumer products, primarily trackside event souvenir merchandising. The company was founded in 1959 and is based in Concord, North Carolina.

Advisors' Opinion:

• [By Patricio Kehoe]

  The motorsports industry is a natural monopoly at the local level, since only one racetrack can hold NASCAR events in each market, and until now, International Speedway has won this battle. Nevertheless, over the past five years, this company has suffered under declining ticket and concession spending, due to a weak demographic fan base located in troubled geographies. Although recent racetrack changes and customer stabilization will leave ISCA well positioned when spending power increases once again, this is bound to happen at a slow pace. However, the distinct properties of each racetrack attract high brand loyalty, and have compelled competitors like Speedway Motorsports Inc. (TRK) to focus business on completely different markets, therefore posing no real threat to ISCA.

5 Best Logistics Stocks To Own For 2014: Ensign Group Inc (ENSG)

The Ensign Group, Inc., incorporated in 1999, is a holding company. The Company is a provider of skilled nursing and rehabilitative care services through the operation of 103 facilities, five home health and three hospice operations located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas, Utah and Washington. Its facilities provide a spectrum of skilled nursing, assisted living, home health and hospice services, including physical, occupational and speech therapies, and other rehabilitative and healthcare services, for both long-term residents and short-stay rehabilitation patients. Its walk-in clinics will offer daily access to healthcare for minor injuries and illnesses, including x-ray and lab services, all from convenient neighborhood locations with no appointments. In March 2014, the Company acquired Horizon Post-Acute and Rehabilitation Center, a 196-bed skilled nursing facility in Glendale, Arizona.

On January 1, 2011, the Company purchased one skilled nursing facility which also offers assisted living and independent living services and one independent living facility. On February 1, 2011, the Company purchased one skilled nursing facility in Utah, which also offers assisted living and independent living services. On March 18, 2011, the Company purchased one assisted living facility in California. On May 15, 2011, the Company purchased a home health and hospice operation in Utah. On June 1, 2011, the Company purchased an assisted living facility in Nevada. On July 18, 2011, the Company acquired nine skilled nursing facilities. On August 1, 2011, the Company acquired a skilled nursing facility in Texas; the Company acquired a skilled nursing facility in Utah, and the Company acquired an independent living facility. On October 1, 2011, the Company acquired a skilled nursing facility in California. On December 1, 2011, the Company acquired a skilled nursing facility in Nevada. On December 30, 2011, the Company acquired an assisted living facility in Ari! zona. In November 2011, the Company acquired Pocatello Care and Rehabilitation Center. On November 22, 2011, the Company acquired Homecare Solutions.

The Company's facilities provide a range of skilled nursing and assisted living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services, for both long-term residents and short-stay rehabilitation patients. As of December 31, 2011, it operated 102 facilities, of which it owned 77 and operated an additional 25 facilities under long-term lease arrangements, and had options to purchase five of those 25 facilities.

The Company's wholly owned subsidiaries, which include the Service Center, provides centralized accounting, payroll, human resources, information technology, legal, risk management and other centralized services to the other operating subsidiaries through contractual relationships with such subsidiaries. The Company also has a wholly owned captive insurance subsidiary (the Captive) that provides some claims-made coverage to the Company's operating subsidiaries for general and professional liability, as well as coverage for some workers' compensation insurance liabilities.

Skilled nursing facility revenue is primarily derived from Medicaid, private pay, managed care and Medicare payors. The Company�� skilled nursing facilities provide Medicaid-covered services to individuals consisting of nursing care, room and board and social services. Rehabilitation therapy revenue is primarily received from private pay and Medicare for services provided at skilled nursing facilities and assisted living facilities. Assisted living facility revenue is primarily derived from private pay residents. In addition, Medicaid or other programs in some states where it operates supplement payments for board and care services provided in assisted living facilities. Hospice revenues are primarily derived from Medicare. It derives substantially all of the revenue from its home health busines! s from Me! dicare and Managed Care sources. Its home health care services generally consist of providing some combination of the services of registered nurses, speech, occupational and physical therapists, medical social workers and certified home health aides.

Advisors' Opinion:

• [By Jim Royal]

  The business and special situation
  CareTrust was spun out of The Ensign Group (NASDAQ: ENSG  ) nearly six months ago, and it's done little but decline since then. CareTrust is a small REIT -- market cap of about $360 million -- that owns healthcare properties. Right now its portfolio is comprised almost exclusively of Ensign's former real estate, 143 locations, leaving the REIT exposed to entirely one operator. However, rent coverage is excellent and Ensign is one of the best healthcare operators around.